American Association for Cancer Research

SHERPA: Unknown

People

  1. Solit
    Solit
  2. Ladanyi
    Ladanyi
  3. Rosen
    Rosen
  4. Hudis
    Hudis
  5. Scher
    Scher
  6. Baselga
    Baselga
  7. Berger
    Berger
  8. Norton
    Norton
  9. Reis-Filho
    Reis-Filho
  10. Cordon-Cardo
    Cordon-Cardo

Groups

  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)
  7. Human Oncology and Pathogenesis Program (687)
  8. Surgery (647)
  9. Breast Medicine Service (611)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (589)
Search Within
Formats
  1. Journal Article (2035)
  2. Meeting Abstract (2011)
  3. Editorial (49)
  4. Review (29)
  5. Conference Paper (14)
  6. Correspondence (6)
  7. Miscellaneous (4)
  8. Guidelines (1)
Groups
  1. Department of Medicine (2138)
  2. Solid Tumor Oncology Division (1789)
  3. GSK Faculty (1641)
  4. Sloan Kettering Institute Faculty (788)
  5. Sloan Kettering Institute Postdocs (787)
  6. Department of Pathology and Laboratory Medicine (744)

More Groups

People
  1. David Solit (176)
  2. Marc Ladanyi (158)
  3. Neal Rosen (142)
  4. Clifford Hudis (141)
  5. Howard Scher (139)
  6. Jose Baselga (138)

More People

Years
  1. 2025 (51)
  2. 2024 (75)
  3. 2023 (79)
  4. 2022 (266)
  5. 2021 (235)
  6. 2020 (272)

More Years

Publications
  1. Cancer Research (2704)
  2. Clinical Cancer Research (1445)

Results (4149)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Results from a first-in-human phase I study of siremadlin (HDM201) in patients with advanced wild-type TP53 solid tumors and acute leukemia
    Journal Article

    Stein, E. M.; DeAngelo, D. J.; Chromik, J.; Chatterjee, M.; Bauer, S.; Lin, C. C.; Suarez, C.; de Vos, F.; Steeghs, N.; Cassier, P. A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • The effect of corticosteroids on prostate cancer outcome following treatment with enzalutamide: A multivariate analysis of the phase III AFFIRM Trial
    Journal Article

    Zhao, J. L.; Fizazi, K.; Saad, F.; Chi, K. N.; Taplin, M. E.; Sternberg, C. N.; Armstrong, A. J.; de Bono, J. S.; Duggan, W. T.; Scher, H. I.
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Long-term follow-up and patterns of response, progression, and hyperprogression in patients after PD-1 blockade in advanced sarcoma
    Journal Article

    Klemen, N. D.; Hwang, S.; Bradic, M.; Rosenbaum, E.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; Movva, S.; Thornton, K. A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • From basic science to clinical translation in kidney cancer: A report from the Second Kidney Cancer Research Summit
    Editorial

    Choueiri, T. K.; Albiges, L.; Atkins, M. B.; Bakouny, Z.; Bratslavsky, G.; Braun, D. A.; Haas, N. B.; Haanen, J. B. A. G.; Hakimi, A. A.; Jewett, M. A. S.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Rules of engagement: The lymphocyte receptor ecosystem in renal cell carcinoma
    Editorial

    Krishna, C.; Hakimi, A. A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • CIC-mediated modulation of MAPK signaling opposes receptor tyrosine kinase inhibitor response in kinase-addicted sarcoma
    Journal Article

    Odintsov, I.; Ortiz, M. V.; Khodos, I.; Mattar, M. S.; Lui, A. J. W.; Kohsaka, S.; de Stanchina, E.; Glade Bender, J. L.; Ladanyi, M.; Somwar, R.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Beyond T cells: IgA incites immune recognition in endometrial cancer
    Editorial

    Osorio, J. C.; Zamarin, D.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Association of neutrophil-to-lymphocyte ratio with efficacy of first-line avelumab plus axitinib vs. sunitinib in patients with advanced renal cell carcinoma enrolled in the phase 3 JAVELIN Renal 101 trial
    Journal Article

    Bilen, M. A.; Rini, B. I.; Voss, M. H.; Larkin, J.; Haanen, J. B. A. G.; Albiges, L.; Pagliaro, L. C.; Voog, E. G.; Lam, E. T.; Kislov, N.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Recognizing unmet need in the era of targeted therapy for CLL/SLL: “What's past Is prologue” (Shakespeare)
    Journal Article

    Mato, A. R.; Davids, M. S.; Sharman, J.; Roeker, L. E.; Kay, N.; Kater, A. P.; Rogers, K.; Thompson, M. C.; Rhodes, J.; Goy, A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Targeting ribonucleotide reductase induces synthetic lethality in PP2A-deficient uterine serous carcinoma
    Journal Article

    O'Connor, C. M.; Taylor, S. E.; Miller, K. M.; Hurst, L.; Haanen, T. J.; Suhan, T. K.; Zawacki, K. P.; Noto, F. K.; Trako, J.; Mohan, A.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: